Eagle Asset Management Inc. cut its holdings in Colgate-Palmolive (NYSE:CL) by 3.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 29,720 shares of the company’s stock after selling 928 shares during the period. Eagle Asset Management Inc.’s holdings in Colgate-Palmolive were worth $2,108,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Jacobi Capital Management LLC boosted its holdings in shares of Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after acquiring an additional 803 shares in the last quarter. Krilogy Financial LLC boosted its holdings in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after acquiring an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new stake in shares of Colgate-Palmolive in the second quarter valued at about $122,000. AlphaMark Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after acquiring an additional 25 shares in the last quarter. Finally, Bruderman Asset Management LLC purchased a new stake in shares of Colgate-Palmolive in the second quarter valued at about $126,000. Institutional investors own 71.52% of the company’s stock.
Shares of Colgate-Palmolive (CL) opened at $70.30 on Friday. The company has a market cap of $61,535.49, a PE ratio of 24.49, a P/E/G ratio of 2.60 and a beta of 0.75. Colgate-Palmolive has a fifty-two week low of $68.19 and a fifty-two week high of $77.91. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend was Monday, January 22nd. Colgate-Palmolive’s payout ratio is currently 70.18%.
CL has been the topic of several analyst reports. Citigroup lowered their target price on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a report on Thursday, November 2nd. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday, November 1st. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective on the stock in a report on Tuesday, December 19th. Finally, Deutsche Bank assumed coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $77.91.
In other Colgate-Palmolive news, insider Daniel B. Marsili sold 5,692 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $70.19, for a total transaction of $399,521.48. Following the completion of the transaction, the insider now owns 41,677 shares in the company, valued at $2,925,308.63. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP John J. Huston sold 14,000 shares of Colgate-Palmolive stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $69.44, for a total transaction of $972,160.00. Following the transaction, the senior vice president now owns 100,508 shares of the company’s stock, valued at approximately $6,979,275.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 463,082 shares of company stock valued at $32,983,130. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.